ENTERA BIO LTD's ticker is ENTX and the CUSIP is M40527109. A total of 7 filers reported holding ENTERA BIO LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445 | -50.4% | 614 | -42.3% | 0.00% | – |
| Q2 2023 | $897 | -92.1% | 1,064 | -89.1% | 0.00% | – |
| Q1 2023 | $11,298 | +49.0% | 9,740 | -6.2% | 0.00% | – |
| Q4 2022 | $7,583 | +279.2% | 10,388 | +492.2% | 0.00% | – |
| Q3 2022 | $2,000 | -80.0% | 1,754 | -76.3% | 0.00% | – |
| Q2 2022 | $10,000 | -23.1% | 7,404 | +58.9% | 0.00% | – |
| Q1 2022 | $13,000 | +333.3% | 4,660 | +724.8% | 0.00% | – |
| Q3 2021 | $3,000 | -50.0% | 565 | -44.7% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 1,022 | -36.7% | 0.00% | – |
| Q1 2021 | $6,000 | +500.0% | 1,614 | +243.4% | 0.00% | – |
| Q4 2020 | $1,000 | -90.0% | 470 | -94.0% | 0.00% | – |
| Q3 2020 | $10,000 | -47.4% | 7,838 | -24.5% | 0.00% | – |
| Q2 2020 | $19,000 | +1800.0% | 10,382 | +1574.5% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 620 | +33.3% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 465 | -32.3% | 0.00% | – |
| Q2 2019 | $2,000 | -60.0% | 687 | -39.6% | 0.00% | – |
| Q1 2019 | $5,000 | +150.0% | 1,137 | +211.5% | 0.00% | – |
| Q3 2018 | $2,000 | -77.8% | 365 | -74.6% | 0.00% | – |
| Q2 2018 | $9,000 | – | 1,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,275 | $1,801,099 | 1.87% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 345 | $250 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,597 | $12,757 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11,374 | $8,246 | 0.00% |
| MORGAN STANLEY | 1,000 | $725 | 0.00% |
| Citadel Advisors | 10,700 | $7,758 | 0.00% |
| Citadel Advisors | 100 | $73 | 0.00% |
| Citadel Advisors | 15,368 | $11,142 | 0.00% |
| HighTower Advisors, LLC | 11,830 | $9,000 | 0.00% |